- Home
- OGE vs EXEL Comparison
OGE vs EXEL Comparison
Compare OGE & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGE
- EXEL
- Stock Information
- Founded
- OGE 1902
- EXEL 1994
- Country
- OGE United States
- EXEL United States
- Employees
- OGE N/A
- EXEL N/A
- Industry
- OGE Electric Utilities: Central
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OGE Utilities
- EXEL Health Care
- Exchange
- OGE Nasdaq
- EXEL Nasdaq
- Market Cap
- OGE 8.3B
- EXEL 9.7B
- IPO Year
- OGE N/A
- EXEL 2000
- Fundamental
- Price
- OGE $43.83
- EXEL $34.83
- Analyst Decision
- OGE Buy
- EXEL Buy
- Analyst Count
- OGE 7
- EXEL 18
- Target Price
- OGE $38.67
- EXEL $31.72
- AVG Volume (30 Days)
- OGE 1.4M
- EXEL 2.6M
- Earning Date
- OGE 11-05-2024
- EXEL 10-29-2024
- Dividend Yield
- OGE 3.85%
- EXEL N/A
- EPS Growth
- OGE N/A
- EXEL 441.02
- EPS
- OGE 1.93
- EXEL 1.55
- Revenue
- OGE $2,791,500,000.00
- EXEL $2,081,598,000.00
- Revenue This Year
- OGE $8.29
- EXEL $20.53
- Revenue Next Year
- OGE $4.97
- EXEL $1.54
- P/E Ratio
- OGE $22.63
- EXEL $22.42
- Revenue Growth
- OGE N/A
- EXEL 17.31
- 52 Week Low
- OGE $32.06
- EXEL $19.20
- 52 Week High
- OGE $44.09
- EXEL $36.60
- Technical
- Relative Strength Index (RSI)
- OGE 65.59
- EXEL 68.57
- Support Level
- OGE $42.36
- EXEL $33.82
- Resistance Level
- OGE $43.22
- EXEL $36.49
- Average True Range (ATR)
- OGE 0.96
- EXEL 0.78
- MACD
- OGE 0.14
- EXEL -0.27
- Stochastic Oscillator
- OGE 94.79
- EXEL 37.68
About OGE OGE Energy Corp
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution to 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.